Lidonex Liquid
NDC Package 73564-804-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lidonex (lidocaine hcl, menthol) liquids is useFor temporarily relief of pain. This formulation utilizes a liquid delivery system. Marketed by Aldama Pharmaceuticals, Inc, this product is identified by NDC 73564-804 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
73564-804-02
Package Description
60 mL in 1 BOTTLE
Product Code
73564-804
11-Digit Billing Format
73564080402
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
60 ML
RxNorm Crosswalk
  • RxCUI: 2715395 - lidocaine HCl 4 % / menthol 5 % Topical Solution
  • RxCUI: 2715395 - lidocaine hydrochloride 40 MG/ML / menthol 50 MG/ML Topical Solution

Clinical Specifications

Proprietary Name
Lidonex
Non-Proprietary Name
Lidocaine Hcl, Menthol
Substance Name
Lidocaine Hydrochloride; Menthol
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
UseFor temporarily relief of pain

Regulatory & Marketing

Labeler Name
Aldama Pharmaceuticals, Inc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73564-804-02 identifies a specific commercial package of 60 ml in 1 bottle of Lidonex, a human over the counter drug labeled by Aldama Pharmaceuticals, Inc. This product is billed per "ML" milliliter and contains an estimated amount of 60 billable units per package. This liquid is formulated for topical use and contains lidocaine hydrochloride; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aldama Pharmaceuticals, Inc on June 01, 2026. The current certification is valid through December 31, 2027.

How is this Aldama Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73564080402. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73564-804-02
11-Digit CMS (5-4-2)
73564-0804-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.